The first Emergent Biosolutions trade was made in Q1 2013.
Since then Ken Fisher bought shares thirteen more times and sold shares on 24 occasions. The investor completely sold their stake between Q3 2022 and Q4 2022.
Avg closing price
Price range
Sold -500 Thousand shares
Q4 2022
Avg closing price
$15.48
Price range
$11.00
-
$21.45
Sold 7.7% shares (-41.7 Thousand shares)
Q3 2022
Avg closing price
$27.83
Price range
$20.09
-
$35.80
Increased shares by 11.5% (+56 Thousand shares)
Q2 2022
Avg closing price
$34.14
Price range
$27.42
-
$43.63
Sold 2.5% shares (-12.5 Thousand shares)
Q1 2022
Avg closing price
$44.11
Price range
$36.48
-
$52.22
Sold 5.8% shares (-30.6 Thousand shares)
Q4 2021
Avg closing price
$45.24
Price range
$33.11
-
$55.01
Increased shares by 6.7% (+33.4 Thousand shares)
Q3 2021
Avg closing price
$60.56
Price range
$50.07
-
$66.05
Increased shares by 2.8% (+13.7 Thousand shares)
Q2 2021
Avg closing price
$64.24
Price range
$56.61
-
$80.46
Sold 0.7% shares (-3.62 Thousand shares)
Q1 2021
Avg closing price
$102.42
Price range
$86.23
-
$125.19
Sold 3.4% shares (-17.3 Thousand shares)
Q4 2020
Avg closing price
$91.78
Price range
$79.17
-
$111.47
Sold 10.2% shares (-57.3 Thousand shares)
Q3 2020
Avg closing price
$107.80
Price range
$81.91
-
$134.94
Sold 4.4% shares (-25.9 Thousand shares)
Q2 2020
Avg closing price
$74.52
Price range
$54.33
-
$89.52
Sold 7.1% shares (-45 Thousand shares)
Q1 2020
Avg closing price
$57.63
Price range
$49.34
-
$68.76
Sold 4.6% shares (-30.6 Thousand shares)
Q4 2019
Avg closing price
$54.24
Price range
$51.21
-
$59.06
Increased shares by 0.5% (+3.61 Thousand shares)
Q3 2019
Avg closing price
$46.58
Price range
$40.60
-
$57.20
Increased shares by 23.3% (+124 Thousand shares)
Q2 2019
Avg closing price
$47.92
Price range
$39.92
-
$53.86
Increased shares by 6.2% (+31.4 Thousand shares)
Q1 2019
Avg closing price
$58.99
Price range
$48.23
-
$66.16
Increased shares by 67.1% (+202 Thousand shares)
Q4 2018